116 related articles for article (PubMed ID: 30668984)
1. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation.
Mohammadpour H; Tsuji T; MacDonald CR; Sarow JL; Rosenheck H; Daneshmandi S; Choi JE; Qiu J; Matsuzaki J; Witkiewicz AK; Attwood K; Blazar BR; Odunsi K; Repasky EA; McCarthy PL
Cell Rep; 2023 Mar; 42(3):112250. PubMed ID: 36924493
[TBL] [Abstract][Full Text] [Related]
3. Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Mo F; Watanabe N; Omdahl KI; Burkhardt PM; Ding X; Hayase E; Panoskaltsis-Mortari A; Jenq RR; Heslop HE; Kean LS; Brenner MK; Tkachev V; Mamonkin M
Blood; 2023 Mar; 141(10):1194-1208. PubMed ID: 36044667
[TBL] [Abstract][Full Text] [Related]
4. The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease.
Chen Y; Zhao Y; Cheng Q; Wu D; Liu H
J Immunol Res; 2015; 2015():145859. PubMed ID: 26090477
[TBL] [Abstract][Full Text] [Related]
5. Human amniotic epithelial stem cell is a cell therapy candidate for preventing acute graft-versus-host disease.
Yang PJ; Zhao XY; Kou YH; Liu J; Ren XY; Zhang YY; Wang ZD; Ge Z; Yuan WX; Qiu C; Tan B; Liu Q; Shi YN; Jiang YQ; Qiu C; Guo LH; Li JY; Huang XJ; Yu LY
Acta Pharmacol Sin; 2024 May; ():. PubMed ID: 38802569
[TBL] [Abstract][Full Text] [Related]
6. Obese donor mice splenocytes aggravated the pathogenesis of acute graft-versus-host disease via regulating differentiation of Tregs and CD4
Li Z; Gu J; Zhu Q; Liu J; Lu H; Lu Y; Wang X
Oncotarget; 2017 Sep; 8(43):74880-74896. PubMed ID: 29088831
[TBL] [Abstract][Full Text] [Related]
7. Metabolic instruction of the graft-versus-leukemia immunity.
Burk AC; Apostolova P
Front Immunol; 2024; 15():1347492. PubMed ID: 38500877
[TBL] [Abstract][Full Text] [Related]
8. Blockade of CCR5 and CXCR3 attenuates murine acute graft-versus-host disease through modulating donor-derived T cell distribution and function.
Tang B; Qin C; Liu H; Miao S; Xue C; Wang Z; Zhang Y; Dong Y; Liu W; Ren H
Int Immunol; 2024 May; ():. PubMed ID: 38778574
[TBL] [Abstract][Full Text] [Related]
9. Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell Transplantation.
Rowley SD; Gunning TS; Pelliccia M; Della Pia A; Lee A; Behrmann J; Bangolo A; Jandir P; Zhang H; Kaur S; Suh HC; Donato M; Albitar M; Ip A
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611035
[TBL] [Abstract][Full Text] [Related]
10. Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity.
Larson JH; Jin S; Loschi M; Bolivar Wagers S; Thangavelu G; Zaiken MC; McDonald-Hyman C; Saha A; Aguilar EG; Koehn B; Osborn MJ; Panoskaltsis-Mortari A; Macdonald KPA; Hill GR; Murphy WJ; Serody JS; Maillard I; Kean LS; Kim SV; Littman DR; Blazar BR
Am J Transplant; 2023 Aug; 23(8):1102-1115. PubMed ID: 36878433
[TBL] [Abstract][Full Text] [Related]
11. Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease.
Moe A; Rayasam A; Sauber G; Shah RK; Doherty A; Yuan CY; Szabo A; Moore BM; Colonna M; Cui W; Romero J; Zamora AE; Hillard CJ; Drobyski WR
J Clin Invest; 2024 Apr; 134(11):. PubMed ID: 38662453
[TBL] [Abstract][Full Text] [Related]
12. Donor whole blood DNA methylation is not a strong predictor of acute graft
Webster AP; Ecker S; Moghul I; Liu X; Dhami P; Marzi S; Paul DS; Kuxhausen M; Lee SJ; Spellman SR; Wang T; Feber A; Rakyan V; Peggs KS; Beck S
Front Genet; 2024; 15():1242636. PubMed ID: 38633407
[TBL] [Abstract][Full Text] [Related]
13. Research advances on short-chain fatty acids in gastrointestinal acute graft-
Song X; Lao J; Wang L; Liu S
Ther Adv Hematol; 2024; 15():20406207241237602. PubMed ID: 38558826
[TBL] [Abstract][Full Text] [Related]
14. Reduced mitochondrial respiration in peripheral T cells after paediatric heamatopoietic stem cell transplantation.
Mølgaard K; Kielsen K; Ifversen M; Met Ö; Svane IM; Müller K
Front Immunol; 2023; 14():1327977. PubMed ID: 38268913
[TBL] [Abstract][Full Text] [Related]
15. Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies.
Naserian S; Leclerc M; Shamdani S; Uzan G
Front Immunol; 2020; 11():607030. PubMed ID: 33391276
[TBL] [Abstract][Full Text] [Related]
16. The Evolution of Hematopoietic Stem Cell Transplantation to Overcome Access Disparities: The Role of NMDP.
Devine SM
Cells; 2024 May; 13(11):. PubMed ID: 38891065
[TBL] [Abstract][Full Text] [Related]
17. Cell-free RNA Liquid Biopsy to Monitor Hematopoietic Stem Cell Transplantation.
Loy C; Cheng MP; Gonzalez-Bocco IH; Lenz J; Belcher E; Bliss A; Eweis-LaBolle D; Chu T; Ritz J; De Vlaminck I
medRxiv; 2024 May; ():. PubMed ID: 38798589
[TBL] [Abstract][Full Text] [Related]
18. IL-22, a new beacon in gastrointestinal aGVHD.
Mohty M; Malard F
Blood; 2023 Mar; 141(12):1369-1370. PubMed ID: 36951884
[No Abstract] [Full Text] [Related]
19. Acute Graft-versus-Host Disease.
Zhang M; Cai J; Gulati V; Khoshpouri P; Orsi M
Radiographics; 2024 Jul; 44(7):e230238. PubMed ID: 38870045
[No Abstract] [Full Text] [Related]
20. Serum MicroRNA-155 in Acute Graft-Versus-Host-Disease (aGVHD).
Efebera YA; Ruppert AS; Ngankeu A; Garman S; Kumchala P; Howard A; Devine SM; Ranganathan P; Garzon R
Int J Bone Marrow Res; 2019; 2():079-82. PubMed ID: 34079960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
